Connect with us
[the_ad id="89560"]

Addictions

Alberta’s recovery-focused addiction agency to address data gap

Published

8 minute read

By Alexandra Keeler

The launch of Alberta’s Centre of Recovery Excellence comes as Ontario and Saskatchewan also shift to recovery-oriented models

This fall, Alberta will be launching a new agency to lead recovery-focused addiction research and treatment in the province.

The Canadian Centre of Recovery Excellence (CoRE) aims to address a major challenge in Canada’s toxic drug crisis: a shortage of evidence-based, recovery-oriented research.

“[W]e hope to … support individuals on their recovery journey using the best available evidence on what works and what does not work,” the centre’s communications lead Katy Merrifield told Canadian Affairs in a written statement.

“There is also a lack of tangible research centred on the outcomes of recovery-focused policy, which is what CoRE aims to address,” she said.

The move comes at a time when Ontario and Saskatchewan are also shifting their policy responses away from harm-reduction strategies — such as safe consumption sites and needle exchange programs — toward more recovery-oriented models.

Last week, Ontario announced it would be closing 10 safe consumption sites located near daycares and schools and opening 19 recovery hubs. It also plans to prevent municipalities from establishing new consumption sites, requesting the decriminalization of illegal drugs or participating in federal safe supply initiatives, Canadian Affairs reported last week.

Early signs of success

CoRE’s launch is part of Alberta’s broader approach to addiction under the United Conservative Party government. The party, which has been in power since 2019, favours a recovery-oriented approach over a harm-reduction model.

In 2019, Alberta committed $140 million over four years to enhance addiction services, which has increased the number of available treatment spaces from 19,000 to 29,400. The province has eliminated a $40-a-day user fee at publicly funded addiction treatment facilities. And it has authorized police officers to assist detainees in seeking treatment.

The number of opioid-related deaths in the first three months of 2024 was 452, down from a high of 627 deaths in Q1 2023. However, it is still above the 241 deaths registered in the first quarter of 2020, according to the Alberta Substance Use Surveillance System.

Despite these early signs of success, the province would like to see further data to support its recovery-focused policy decisions.

“There is no clear centre of recovery excellence that can advise on what works and does not work when it comes to mental health and addictions,” Alberta’s Minister of Mental Health and Addiction Dan Williams said April 2 when announcing the creation of CoRE.

“One challenge with addiction research, and research in general, is there is often an attempt to look at a very specific intervention over a short period of time,” said Merrified. “[B]roader, long-term research is time consuming and expensive.”

CoRE will investigate the number of Albertans affected by addiction, their recovery journeys and outcomes, such as return to work, access to housing and family reunification.

The agency also plans to integrate global best practices into Alberta’s programs.

“From Portugal’s commission for drug dissuasion combined with their massive scale of recovery spaces to Italy’s use of recovery communities, we look forward to incorporating global lessons where applicable,” said Merrifield.

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

Industry funding

Alberta’s 2024 budget committed $5 million in funding to launch CoRE.

Merrifield says CoRE’s funding structure will be a key point of distinction between it and the British Columbia Centre on Substance Use, which is another key player in addiction research and education.

In contrast to CoRE, the B.C. centre prioritizes addiction medicine and harm reduction.

“Our vision is to enable the well-being of people who use substances through evidence-informed, stigma-free policies,” the centre’s website says.

“CoRE has safeguards enshrined in legislation to protect against receiving external funding that could be seen as attempting to bias research results,” said Merrifield, noting the centre will not accept industry funding from pharmaceutical or cannabis companies.

By contrast, the British Columbia Centre on Substance Use does receive funding from the pharmaceutical company Indivior, the pharmacy chain Shoppers Drug Mart and the cannabis companies Tilray and Canopy Growth.

Indivior is the maker of Suboxone, a medication prescribed for opioid dependence. Indivior is currently the subject of at least two class-action lawsuits alleging Indivior failed to disclose Suboxone’s adverse side effects, Canadian Affairs  reported in August.

In 2021, Shoppers Drug Mart offered a $2-million gift to the University of British Columbia to establish a pharmacy fellowship and support the education of pharmacist-focused addiction treatment at the British Columbia Centre on Substance Use.

Asked about the risk that drug industry funding could compromise the objectivity of their research, the B.C. centre referred Canadian Affairs to their website’s funding page. The website states their research is supported by peer-reviewed grants and independent ethical reviews to ensure objectivity.

Similar programs

Kevin Hollett, communications lead for the British Columbia Centre on Substance Use, said the centre is willing to collaborate with CoRE.

“We would welcome opportunities to collaborate and share knowledge with the CoRE team following their operational launch and as they define their research scope,” he said in a written statement.

CoRE was initially slated to be operational this summer, but launch details have not yet been announced.

At a conference on April 4, Minister Williams announced plans for CoRE to collaborate with Ontario and Saskatchewan on recovery-focused treatment systems. Currently, both provinces lack a direct equivalent to CoRE or B.C.’s centre.

“Many jurisdictions are interested in learning from the Alberta Recovery Model and implementing similar programs,” said Merrifield.


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism on addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Break The Needle. Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.

Addictions

BC overhauls safer supply program in response to widespread pharmacy scam

Published on

By Alexandra Keeler

A B.C. pharmacy scam investigation has led the provincial government to return to a witnessed consumption model for safer supply

More than 60 pharmacies across B.C. are alleged to have participated in a kickback scheme linked to safer supply drugs, according to a provincial report released Feb. 19.

On Feb. 5, the BC Conservatives leaked a report that showed the findings of an internal investigation by the B.C. Ministry of Health. That investigation showed dozens of pharmacies were filling prescriptions patients did not require in order to overbill the government. These safer supply drugs were then diverted onto the black market.

After the report was leaked, the province committed to ending take-home safer supply models, which allow users to take hydromorphone pills home in bottles. Instead, it will require drug users to consume prescribed opioids in a witnessed program, under the oversight of a medical professional.

Gregory Sword, whose 14-year-old daughter Kamilah died in August 2022 after taking a hydromorphone pill that had been diverted from B.C.’s safer supply program, expressed outrage over the report’s findings.

“This is so frustrating to hear that [pharmacies] were making money off this program and causing more drugs [to flood] the street,” Sword told Canadian Affairs on Feb. 20.

The investigation found that pharmacies exploited B.C.’s Frequency of Dispensing policy to maximize billings. To take advantage of dispensing fees, pharmacies incentivized clients to fill prescriptions they did not require by offering them cash or rewards. Some of those clients then sold the drugs on the black market. Pharmacies earned up to $11,000 per patient a year.

“I’m positive that [the B.C. government has] known this for a long time and only made this decision when the public became aware and the scrutiny was high,” said Elenore Sturko, Conservative MLA for Surrey-Cloverdale, who released the leaked report in a statement on Feb. 5.

“As much as I am really disappointed in how long it’s taken for this decision to be made, I am also happy that this has happened,” she said.

The health ministry said it is investigating the implicated pharmacies. Those that are confirmed to have been involved could have their licenses suspended, be referred to law enforcement or become ineligible to participate in PharmaCare, the provincial program that helps residents cover the costs of prescription drugs.

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

 

Witnessed dosing

The leaked report says that “a significant portion of the opioids being freely prescribed by doctors and pharmacists are not being consumed by their intended recipients.” It also says “prescribed alternatives are trafficked provincially, nationally and internationally.”

Critics of the safer supply program say it enables addiction, while supporters say it reduces overdoses.

Sword, Kamilah’s father, is suing the provincial and federal governments, arguing B.C.’s safer supply program made it possible for youth such as his daughter to access drugs.

Madison, Kamilah’s best friend, also became addicted to opioids dispensed through safer supply programs. Madison was just 15 when she first encountered “dillies” — hydromorphone pills dispensed through safer supply, but widely available on the streets. She developed a tolerance that led her to fentanyl.

“I do know for sure that some pharmacies and doctors were aware of the diversion,” Madison’s mother Beth told Canadian Affairs on Feb. 20.

“When I first realized what my daughter was taking and how she was getting it, I phoned the pharmacy and the doctor on the label of the pill bottle to inform them that the patient was selling their hydromorphone,” Beth said.

Masha Krupp, an Ottawa mother who has a son enrolled in a safer supply program, has said the safer supply program in her city is similarly flawed. Canadian Affairs previously reported on this program, which is run by Recovery Care’s Ottawa-based harm reduction clinics.

“I read about the B.C. pharmacy scheme and wasn’t surprised,” Krupp told Canadian Affairs on Feb. 20. Krupp lost a daughter to methadone toxicity while she was in an addiction treatment program at Recovery Care.

“Three years [after starting safer supply], my son is still using fentanyl, crack cocaine and methadone, despite being with Dr. [Charles] Breau and with Recovery Care for over three years,” Krupp testified before the House of Commons Standing Committee on Health on Oct. 22, 2024.

Krupp has been vocal about the dangers of dispensing large quantities of opioids without proper oversight, arguing many patients sell their prescriptions to buy stronger street drugs.

“You can’t give addicts 28 pills and say, ‘Oh here you go,’” she said in her testimony. “They sell for three dollars a pop on the street.”

Krupp has also advocated for witnessed consumption of safer supply medications, arguing supervised dosing would prevent diversion and ensure proper oversight of pharmacies.

“I had talked about witnessed dosing for safe supply when I appeared before the parliamentary health committee last October,” she told Canadian Affairs this week.

“I’m grateful that finally … this decision has been made to return to a witness program,” said Sturko, the B.C. MLA.

In 2020, B.C. implemented a witnessed consumption model to ensure safer supply opioids were consumed as prescribed and to reduce diversion. In 2021, the province switched to take-home models. Its stated aim was to expand access, save lives and ease pressure on health-care facilities during the pandemic.

“You’re really fighting against a group of people … working within the bureaucracy of [the B.C. NDP] government … who have been making efforts to work towards the legalization of drugs and, in doing that, have looked only for opportunities to bolster their arguments for their position, instead of examining their approach in a balanced way,” said Sturko.

“These are foreseeable outcomes when you do not put proper safeguards in place and when you completely ignore all indications of negative impacts.”

Sword also believes some drug policies fail to prioritize the safety of vulnerable individuals.

“Greed is the ultimate evil in society and this just proves it,” he said. We don’t care about these drugs getting into the wrong hands as long as I get my money.”


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.

Continue Reading

Addictions

Calls for Public Inquiry Into BC Health Ministry Opioid Dealing Corruption

Published on

Sam Cooper

The leaked audit shows from 2022 to 2024, a staggering 22,418,000 doses of opioids were prescribed by doctors and pharmacists to approximately 5,000 clients in B.C., including fentanyl patches.

A confidential investigation by British Columbia’s Ministry of Health, Financial Operations and Audit Branch has uncovered explosive allegations of fraud, abuse, and organized crime infiltration within PharmaCare’s prescribed opioid alternatives program. Internal audit findings, obtained by The Bureau, suggest that millions of taxpayer dollars are being diverted into illicit drug trafficking networks rather than serving harm reduction efforts.

The leaked documents include photographs from vehicle searches that show collections of fentanyl patches and Dilaudid (hydromorphone) apparently packaged for resale after being stolen from the taxpayer-funded “safer supply” program. This program expanded dramatically following a federal law change implemented by Prime Minister Justin Trudeau’s government in 2020, which broadened circumstances in which pharmacy staff could dispense opioids, according to the document’s evidence.

“Prior to March 17, 2020, only pharmacists in BC were permitted to deliver [addiction therapy treatment] drugs,” the audit says.

B.C.’s safer supply program was launched in March 2020 as a response to the opioid overdose crisis, declared in 2016. It allows people with opioid-use disorder to receive prescribed drugs to be used on-site or taken away for later use.

The Special Investigations Unit and PharmaCare Audit Intelligence team identified a disturbing link between doctors, pharmacists, assisted living residences, and organized crime, where prescription opioids meant to replace illicit drugs are instead being diverted, sold, and trafficked at scale.

“A significant portion of the opioids being freely prescribed by doctors and pharmacists are not being consumed by their intended recipients,” the document states.

It suggests that financial incentives have created a business model for organized crime, asserting that “prescribed alternatives (safe supply opioids) are trafficked provincially, nationally, and internationally,” and that “proceeds of fraud” are being used to pay incentives to doctors, pharmacists, and intermediaries.

BC Conservative critic Elenore Sturko, a former RCMP officer, began raising concerns about the program two years ago after hearing anecdotes about prescribed opioids being trafficked. She asserts that the program is a failure in public policy and insists that Provincial Health Officer Dr. Bonnie Henry be dismissed for having “denied and downplayed” problems as they emerged. Sturko also argues that B.C. must change its drug policy in light of U.S. President Donald Trump’s stance linking the trafficking of fentanyl and other opioids to potential trade sanctions against Canada.

The document shows that PharmaCare’s dispensing fee loophole has incentivized pharmacies to maximize billings per patient, with some locations charging up to $11,000 per patient per year—compared to just $120 in normal cases.

Perhaps most alarming is the deep infiltration of B.C.’s safer supply program by criminal networks. The Ministry of Health report lists “Gang Members/Organized Crime” as key players in the prescription drug pipeline, which includes “Doctors, pharmacies, and assisted living residences.”

This revelation confirms long-standing fears that B.C.’s “safe supply” policy—originally designed to prevent deaths from contaminated street drugs—is instead sometimes supplying criminal organizations with pharmaceutical-grade opioids.

The leaked audit shows from 2022 to 2024, a staggering 22,418,000 doses of opioids were prescribed by doctors and pharmacists to approximately 5,000 clients in B.C., including fentanyl patches.

Beyond organized crime’s direct involvement, pharmacies themselves have exploited regulatory gaps to generate massive profits from PharmaCare’s policies:

  • Pharmacies offer kickbacks to doctors, housing staff, and medical professionals to steer patients toward specific locations.
  • Financial incentives fuel fraud, with multiple investigations identifying 60+ pharmacies offering incentives to clients.
  • Non-health professionals, including housing staff, are witnessing OAT (opioid agonist treatment) dosing, violating patient safety protocols.

The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

For the full experience, please upgrade your subscription and support a public interest startup. We break international stories and this requires elite expertise, time and legal costs.

Continue Reading

Trending

X